Hochschulschrift
Pharmacokinetic/pharmacodynamic-guided optimisation of monoclonal antibody therapy in special populations
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISBN
-
9783844057645
3844057641
- Maße
-
21 cm, 311 g
- Umfang
-
xviii, 189 Seiten
- Ausgabe
-
[1. Auflage]
- Sprache
-
Englisch
- Anmerkungen
-
Illustrationen
Freie Universität Berlin, Dissertation, 2017
- Schlagwort
-
Crohn-Krankheit
Pharmakokinetik
Pharmakodynamik
Monoklonaler Antikörper
Infliximab
Crohn-Krankheit
Enteritis
Darmentzündung
Antikörper
B-Lymphozyt
Immunpharmakologie
Immunsuppressivum
- Ereignis
-
Veröffentlichung
- (wo)
-
Aachen
- (wer)
-
Shaker
- (wann)
-
2018
- Urheber
- Beteiligte Personen und Organisationen
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2025, 13:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
- Edlund, Helena
- Shaker Verlag
- Shaker
Entstanden
- 2018
Ähnliche Objekte (12)
Population pharmacokinetic analysis for the therapeutic anti-EGFR humanised monoclonal antibody matuzumab
Monoclonal antibody therapy
Dynamic optimization strategies for monoclonal antibody production
Intensification of cell clarification in monoclonal antibody manufacturing
Optimised freezing and thawing of monoclonal antibody solutions
Quality-targeting dynamic optimization of monoclonal antibody production
Monoclonal antibody targeting of ABCB5 in human malignant melanoma
X-ray structure of the murine monoclonal antibody MAK33
Stress‐induced increase of monoclonal antibody production in CHO cells
Development and monotoring of a novel monoclonal antibody purification strategy
Stress-induced increase of monoclonal antibody production in CHO cells
Development and monitoring of a novel monoclonal antibody purification strategy
Population pharmacokinetic analysis for the therapeutic anti-EGFR humanised monoclonal antibody matuzumab
Monoclonal antibody therapy
Dynamic optimization strategies for monoclonal antibody production
Intensification of cell clarification in monoclonal antibody manufacturing
Optimised freezing and thawing of monoclonal antibody solutions
Quality-targeting dynamic optimization of monoclonal antibody production
Monoclonal antibody targeting of ABCB5 in human malignant melanoma
X-ray structure of the murine monoclonal antibody MAK33
Stress‐induced increase of monoclonal antibody production in CHO cells
Development and monotoring of a novel monoclonal antibody purification strategy
Stress-induced increase of monoclonal antibody production in CHO cells
Development and monitoring of a novel monoclonal antibody purification strategy
Population pharmacokinetic analysis for the therapeutic anti-EGFR humanised monoclonal antibody matuzumab
Monoclonal antibody therapy
Dynamic optimization strategies for monoclonal antibody production
Intensification of cell clarification in monoclonal antibody manufacturing
Optimised freezing and thawing of monoclonal antibody solutions
Quality-targeting dynamic optimization of monoclonal antibody production
Monoclonal antibody targeting of ABCB5 in human malignant melanoma
X-ray structure of the murine monoclonal antibody MAK33
Stress‐induced increase of monoclonal antibody production in CHO cells
Development and monotoring of a novel monoclonal antibody purification strategy
Stress-induced increase of monoclonal antibody production in CHO cells